Study S001237

The Effect of the GLP-1 Receptor Agonists on Blood Levels of Lipoprotein (a)

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT02501850
Acronym: EGLIPA
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: UNKNOWN
Enrollment: 40
Start: 2014-10
Primary completion: 2015-07
Lead sponsor: Hospital Universitari Vall d'Hebron Research Institute
Conditions: Diabetes Mellitus Type 2
Interventions: DRUG:Liraglutide; DRUG:metformin
Results posted: FALSE

Registered primary outcomes

Change in blood levels of Lipoprotein (a) (Lp(a)) [Baseline and two months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.